234 related articles for article (PubMed ID: 32521267)
1. Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer.
Christin JR; Wang C; Chung CY; Liu Y; Dravis C; Tang W; Oktay MH; Wahl GM; Guo W
Cell Rep; 2020 Jun; 31(10):107742. PubMed ID: 32521267
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.
Li Q; Yao Y; Eades G; Liu Z; Zhang Y; Zhou Q
Oncogene; 2014 May; 33(20):2589-600. PubMed ID: 23752191
[TBL] [Abstract][Full Text] [Related]
3. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
[TBL] [Abstract][Full Text] [Related]
4. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6124-9. PubMed ID: 22454501
[TBL] [Abstract][Full Text] [Related]
5. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
Wu J; Crowe DL
Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
[TBL] [Abstract][Full Text] [Related]
6. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
[TBL] [Abstract][Full Text] [Related]
7. A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
Domenici G; Aurrekoetxea-Rodríguez I; Simões BM; Rábano M; Lee SY; Millán JS; Comaills V; Oliemuller E; López-Ruiz JA; Zabalza I; Howard BA; Kypta RM; Vivanco MD
Oncogene; 2019 Apr; 38(17):3151-3169. PubMed ID: 30622340
[TBL] [Abstract][Full Text] [Related]
8. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling.
Chiche A; Di-Cicco A; Sesma-Sanz L; Bresson L; de la Grange P; Glukhova MA; Faraldo MM; Deugnier MA
Breast Cancer Res; 2019 Jan; 21(1):13. PubMed ID: 30683141
[TBL] [Abstract][Full Text] [Related]
9. The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells.
Malhotra GK; Zhao X; Edwards E; Kopp JL; Naramura M; Sander M; Band H; Band V
BMC Dev Biol; 2014 Dec; 14():47. PubMed ID: 25527186
[TBL] [Abstract][Full Text] [Related]
10. SOX9/FXYD3/Src Axis Is Critical for ER
Xue Y; Lai L; Lian W; Tu X; Zhou J; Dong P; Su D; Wang X; Cao X; Chen Y; Wang Q
Mol Cancer Res; 2019 Jan; 17(1):238-249. PubMed ID: 30206184
[TBL] [Abstract][Full Text] [Related]
11. Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.
Xu K; Usary J; Kousis PC; Prat A; Wang DY; Adams JR; Wang W; Loch AJ; Deng T; Zhao W; Cardiff RD; Yoon K; Gaiano N; Ling V; Beyene J; Zacksenhaus E; Gridley T; Leong WL; Guidos CJ; Perou CM; Egan SE
Cancer Cell; 2012 May; 21(5):626-641. PubMed ID: 22624713
[TBL] [Abstract][Full Text] [Related]
12. miRNA-215-5p suppresses the aggressiveness of breast cancer cells by targeting Sox9.
Gao JB; Zhu MN; Zhu XL
FEBS Open Bio; 2019 Nov; 9(11):1957-1967. PubMed ID: 31538724
[TBL] [Abstract][Full Text] [Related]
13. The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population.
Pratt MA; Tibbo E; Robertson SJ; Jansson D; Hurst K; Perez-Iratxeta C; Lau R; Niu MY
Oncogene; 2009 Jul; 28(30):2710-22. PubMed ID: 19483731
[TBL] [Abstract][Full Text] [Related]
14. Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.
Blaas L; Pucci F; Messal HA; Andersson AB; Josue Ruiz E; Gerling M; Douagi I; Spencer-Dene B; Musch A; Mitter R; Bhaw L; Stone R; Bornhorst D; Sesay AK; Jonkers J; Stamp G; Malanchi I; Toftgård R; Behrens A
Nat Cell Biol; 2016 Dec; 18(12):1346-1356. PubMed ID: 27798604
[TBL] [Abstract][Full Text] [Related]
15. Lineage-Biased Stem Cells Maintain Estrogen-Receptor-Positive and -Negative Mouse Mammary Luminal Lineages.
Wang C; Christin JR; Oktay MH; Guo W
Cell Rep; 2017 Mar; 18(12):2825-2835. PubMed ID: 28329676
[TBL] [Abstract][Full Text] [Related]
16. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.
Soyama H; Nishio M; Otani J; Sakuma T; Takao S; Hara S; Masuda T; Mimori K; Toyokuni S; Lydon JP; Nakao K; Nishina H; Fukumoto T; Maehama T; Suzuki A
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2123134119. PubMed ID: 35858357
[TBL] [Abstract][Full Text] [Related]
17. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
18. Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress.
Hein SM; Haricharan S; Johnston AN; Toneff MJ; Reddy JP; Dong J; Bu W; Li Y
Oncogene; 2016 Mar; 35(11):1461-7. PubMed ID: 26096929
[TBL] [Abstract][Full Text] [Related]
19. ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer.
Yan L; Gaddis S; Coletta LD; Repass J; Powell KL; Simper MS; Chen Y; Byrom M; Zhong Y; Lin K; Liu B; Lu Y; Shen J; MacLeod MC
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652981
[TBL] [Abstract][Full Text] [Related]
20. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.
Jiang Z; Deng T; Jones R; Li H; Herschkowitz JI; Liu JC; Weigman VJ; Tsao MS; Lane TF; Perou CM; Zacksenhaus E
J Clin Invest; 2010 Sep; 120(9):3296-309. PubMed ID: 20679727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
